Michigan Biomarker Alliance Joins C-Path Institute's Predictive Safety Testing Consortium | GenomeWeb
NEW YORK (GenomeWeb News) – ClinXus, a non-profit biomarker alliance based in Grand Rapids, Mich., has joined the Critical Path Institute’s Predictive Safety Testing Consortium, ClinXus said today.
 
ClinXus was formed in 2006 using $1.5 million from the Michigan 21st Century Jobs Fund and from in-kind donations from its members, which include the Van Andel Institute, Spectrum Health, Saint Mary’s Health Care, Jasper Clinical Research & Development, Grand Valley State University, and Grand Valley Medical Specialists.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.